Search Results 2731-2740 of 16836 for Epilepsy (Partial Onset)

  1. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers have identified a hidden "movement map" deep within the brain — a discovery that could help surgeons reduce side effects from epilepsy ...

  2. Medical Research & Education - Mayo Clinic News Network

    Gregory Worrell shares how technological innovation is transforming the future of epilepsy care. Latest stories. Research. Bridge the Gap.

  3. A Study Of Inorganic Nitrite To Amplify The Benefits And Tolerability Of Exercise Training In Heart Failure That Has Preserved Ejection Fraction - Mayo Clinic

    Study drug is administered 3 times daily during daytime hours with one of these doses being immediately prior to onset of ET sessions throughout the 12 week ...

  4. Telomere Length Comparison of Diminished and Normal Ovarian Reserve - Mayo Clinic

    Able to get a single blood drawn at Mayo Clinic in Rochester prior to beginning any medications. Exclusion Criteria: Women undergoing ovarian stimulation ...

  5. A Study Of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration - Mayo Clinic

    The purpose of this study is to evaluate the median duration of therapeutic SAA levels with calaspargase pegol. Secondary end points include evaluating a ...

  6. Mayo Clinic

    Vascular medicine consultation. Your Mayo Clinic doctor answers your questions before beginning treatment for a vascular condition.

  7. A Study Of Patidegib Topical Gel, 2%, For The Reduction Of Disease Burden Of Persistently Developing Basal Cell Carcinomas (BCCs) In Subjects With Basal Cell Nevus Syndrome - Mayo Clinic

    The participant is willing to abstain from application of a non-study topical medication (prescription or over the counter) to facial skin for the duration of ...

  8. Neurology - Clinical trials - Mayo Clinic

    A total of 8,000 patients presenting to CPSs with acute-onset AIS, ICH or aSAH and no history of dementia will be enrolled within 6 weeks of stroke onset.

  9. Momelotinib (oral route) - Side effects & dosage - Mayo Clinic

    ... onset of slurred speech, sudden vision changes, or trouble breathing. These may be symptoms of serious blood clots (eg, deep vein thrombosis, pulmonary ...

  10. A Study To Compare The Effectiveness And Safety Of Emixustat Hydrochloride With Placebo To Treat Macular Atrophy Secondary To Stargadt Disease - Mayo Clinic

    The purpose of this study is to determine if emixustat hydrochloride (emixustat) reduces the rate of progression of macular atrophy (MA) compared to placebo in ...